找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Management in Man; Biological Response Paul V. Woolley Book 1989 Kluwer Academic Publishers 1989 Tumor.antibiotics.biology.bone mar

[复制链接]
楼主: STRI
发表于 2025-3-25 05:46:35 | 显示全部楼层
Background on User-Defined Routines,0 and P388 leukemias, and human mammary and colon xenographs, among others (212). In addition, DDP was found to be active by several treatment schedules, against rat as well as mouse tumors, and to be active against tumors of both chemical and biological origins (169). Clinical trials of DDP first b
发表于 2025-3-25 08:48:55 | 显示全部楼层
发表于 2025-3-25 14:12:28 | 显示全部楼层
发表于 2025-3-25 18:23:23 | 显示全部楼层
发表于 2025-3-25 20:57:07 | 显示全部楼层
发表于 2025-3-26 03:46:36 | 显示全部楼层
Biological Response Modifiers, patients with cancer are not necessarily well prepared for the translation of biotherapy to the clinic. Biotherapeutic approaches are broad and involve a whole range of physiological responses inherent in cancer biology. The approaches needed to bring these biotherapeutic capabilities to the clinic
发表于 2025-3-26 04:42:33 | 显示全部楼层
Purine Antimetabolites,imetabolites indeed play a very prominent role. Of 37 experimental anticancer drugs for which INDA’s were filed by the NCI during the period 1977–1983, no less than seven are purine antimetabolites (64). These experimental antipurines are:
发表于 2025-3-26 11:20:13 | 显示全部楼层
Alkylating Agents,e selectively towards a tumour cell rather than towards a normal cell. Selectivity of alkylating agent attack towards tumour cells may also be increased by clinical protection measures on normal tissues (e.g., by autologous bone marrow transplantation). The development of alkylating agent use has th
发表于 2025-3-26 12:52:40 | 显示全部楼层
Platinum Compounds,0 and P388 leukemias, and human mammary and colon xenographs, among others (212). In addition, DDP was found to be active by several treatment schedules, against rat as well as mouse tumors, and to be active against tumors of both chemical and biological origins (169). Clinical trials of DDP first b
发表于 2025-3-26 20:24:28 | 显示全部楼层
Nitrosoureas,nitroso agents (81, 82 and references therein). Structure-activity studies led to the development of chloroethylnitrosoureas and observations that one analog, BCNU,* was curative against L1210 leukemia implanted intracranially or intraperitoneally (51, 105).
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-25 16:37
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表